Psychiatry and Neurology, Neurology · Rio Rancho, NM
NPI
1417248469
Since 2011
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4100 High Resort Blvd SE
Rio Rancho, NM, 87124
Phone (505) 291-2730
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
912 services
Medicare patients, 2024
306
Average age 69
Drug cost, 2024
$1.1M
5,266 prescriptions
Company payments, 2025
$102K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Weiwei Dai was code 99214 (office e&m - established), 291 times for 184 patients. In total Weiwei Dai billed 912 services in 13 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 291 | 184 | $64.51 | $19K |
| 64615 Musculoskeletal | Facility | 233 | 82 | $86.48 | $20K |
| 99213 Office E&M - Established | Facility | 174 | 73 | $44.80 | $7,795 |
| 99204 Office E&M - New | Facility | 66 | 66 | $93.89 | $6,197 |
| 99214 Office E&M - Established | Office | 53 | 49 | $88.70 | $4,701 |
| 99215 Office E&M - Established | Facility | 43 | 38 | $107.33 | $4,615 |
By year: 2022 $60K for 1,051 services; 2023 $66K for 1,276 services; 2024 $66K for 912 services.
Medicare prescription drug claims, 2024
In 2024, the drug Weiwei Dai prescribed most often to Medicare patients was Sumatriptan Succinate, with 458 prescriptions and refills. In total Weiwei Dai wrote 5,266 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sumatriptan Succinate Generic | 458 | 513 | 129 | $18K |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 407 | 411 | 92 | $3,630 |
| Naratriptan Hcl Generic | 273 | 286 | 73 | $6,996 |
| Memantine Hcl Generic | 260 | 652 | 76 | $8,553 |
| Topiramate Generic | 255 | 730 | 101 | $3,769 |
| Gabapentin Generic | 233 | 391 | 57 | $7,065 |
| Aimovig Autoinjector Erenumab-Aooe | 204 | 256 | 34 | $187K |
| Donepezil Hcl Generic | 203 | 520 | 74 | $2,929 |
| Lamotrigine Generic | 184 | 433 | 50 | $3,935 |
| Rizatriptan Rizatriptan Benzoate | 180 | 187 | 70 | $5,429 |
| Levetiracetam Generic | 162 | 456 | 54 | $7,562 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 159 | 443 | 52 | $7,322 |
| Sumatriptan Generic | 129 | 131 | 32 | $14K |
| Primidone Generic | 109 | 255 | 38 | $7,545 |
| Ubrelvy Ubrogepant | 94 | 96 | 39 | $171K |
Brand drugs: 715 claims; generic drugs: 4,529 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Weiwei Dai $102K ($102K in general payments such as food, travel and fees) from 33 companies. The largest payer was Abbvie Inc. with $48K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 144 | $48K |
| Pfizer Inc. PFE | 47 | $31K |
| Lundbeck LLC | 71 | $19K |
| Eisai Inc. 4523.T | 5 | $361 |
| Lilly USA, LLC LLY | 5 | $276 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 2 | $249 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $222 |
| Janssen Biotech, Inc. JNJ | 4 | $194 |
| Biogen, Inc. BIIB | 4 | $186 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $144 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.